BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 06, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Xpert MTB/RIF TB test: Pivotal trial data

Researchers at the FIND (Foundation for Innovative New Diagnostics) and colleagues reported data from an international pivotal trial in 1,730 patients with suspected drug-sensitive or multidrug-resistant pulmonary TB showing that Cepheid's Xpert MTB/RIF assay had 98.2% sensitivity for...

Read the full 177 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >